CVS HEALTH CORPCVS
ASignal's systematic analysis rates CVS as Neutral.
Reflects the latest available analysis · analyzed Oct 28, 2026
The case on CVS
Bull vs bear, surfaced by ASignal's framework agents from public market data. The precise verdict: ASignal Rank, confidence, and price targets - is in the app.
- Forward P/E of 10.55x suggests valuation discount relative to growth
- PEG ratio of 0.22x indicates potential undervaluation given earnings growth
- EV/EBITDA of 10.74x is moderate for Healthcare sector
- Free cash flow of $8.08B supports dividend and reinvestment capacity
- Debt-to-equity ratio of 0.96x is manageable with strong cash flow
- Earnings growth of 188.8% YoY shows strong recent acceleration
- Current RSI of 57.7 near upper end of neutral range, limited near-term upside momentum
- Negative price momentum (-0.02%) suggests short-term downtrend
- MACD above signal line but histogram flattening, indicating trend weakening
- Profit margin of 1.18% and operating margin of 3.86% are low for sector
- ROE of 6.21% indicates subpar capital efficiency
- Current ratio of 0.87x and quick ratio of 0.62x signal liquidity pressure
Peers
Clustered with CVS by analysis-profile similarity.
See the full verdict on CVS
ASignal Rank (1-4), confidence score, Buffett / Ackman / Dalio grades, price targets, and the full reasoning behind the call.
How ASignal analyzes CVS
Most investors never get a second opinion, let alone several. ASignal runs CVS past a panel of specialized investor-framework agents, each calibrated on a distinct school of investing: Warren Buffett's value discipline, Bill Ackman's activist lens, and Ray Dalio's macro view. They don't just score in isolation, they argue: a dedicated Challenger agent pushes back on every conclusion until the panel settles on a reasoned consensus, weighing fundamentals, macro conditions, market sentiment, and price action together. The kind of cross-examined read that takes a research desk hours, ASignal delivers in under two minutes, refreshed every cycle.
The signal direction and the bull and bear case above are free. The precise read, ASignal Rank, framework grades, price targets, and full reasoning, stays with subscribers.